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Sir, 
Surgical site infections (SSIs) after colorectal surgery are an important cause of morbidity and 
mortality.
1
 Prevention of these SSIs by antibiotic prophylaxis is an effective intervention, reported to 
reduce superficial and deep SSI rates from 40% to 10%.
2
 Amoxicillin-clavulanic acid is often 
administered as antibiotic prophylaxis, but resistance to amoxicillin-clavulanic acid has been 
increasing.
3 
It is therefore possible that antibiotic prophylaxis may be becoming less effective. 
Currently, there is limited evidence about the impact of Enterobacteriaceae that are resistant to 
antibiotics on the efficacy of antibiotic prophylaxis in colorectal surgery. To determine the feasibility 
of research into Enterobacteriaceae resistance and SSI risk, we undertook a prospective feasibility 
study. The aims of the study were to estimate the recruitment rate of patients to a study that 
requires pre-operative collection of rectal swabs, and use rectal swabs to estimate the rate of 
antibiotic resistance in Enterobacteriaceae colonising the rectum of patients due for elective 
colorectal surgery. 
Adults due to undergo elective colorectal surgery, defined as incision, excision or anastomosis of the 
large bowel, including anastomosis of small to large bowel, at Leeds Teaching Hospitals were eligible 
to participate in the study. Rectal or stomal swabs were collected from those consenting to 
participate in the study. Swabs were inoculated on an ISA sensitivity test agar plate with a 30µg 
amoxicillin-clavulanic acid disc. Enterobacteriaceae growing nearest to the amoxicillin-clavulanic acid 
disc were subcultured for purity, identified and received susceptibility testing. When more than one 
species of Enterobacteriaceae was identified in a single patient the most resistant isolate with regard 
amoxicillin-clavulanic acid was included in subsequent analysis. Retrospective case note review was 
used to assess for SSIs based on established definitions.
4
 SSIs were assessed in participants who had 
received amoxicillin-clavulanic acid prophylaxis, the recommended standard prophylaxis regimen at 
Leeds Teaching Hospitals. Resistance was defined according to European Committee for 
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Antimicrobial Susceptibility Testing (EUCAST) criteria, whereby the minimum inhibitory 
concentrations (MICs) of amoxicillin-clavulanic acid is >8mg/L.  
The study recruited 58% of potential participants (63/108). Enterobacteriaceae were cultured from 
55/63 (87%) participants, mostly Escherichia coli (47/55, 85%). In total 19% (12/63) of participants 
were colonised with an Enterobacteriaceae resistant to amoxicillin-clavulanic acid. Amoxicillin-
clavulanic acid resistance was present in E. coli (n=6) and Enterobacteriaceae other than E.coli (6). 
SSIs were documented in 7/39 (17.9%) participants who received amoxicillin-clavulanic acid 
prophylaxis. Within these participants SSIs were documented in 2/7 (28.6%) of those colonised with 
an amoxicillin-clavulanic acid resistant Enterobacteriaceae.  This was a higher rate compared to 
those colonised with an amoxicillin-clavulanic acid sensitive Enterobacteriaceae, 5/32 (15.6%). 
Participants colonised with resistant E. coli had a higher SSI rate (2/4, 50%) than participants 
colonised with resistant Enterobacteriaceae other than E. coli (0/3, 0%)(Appendix A/B: Detailed  
methods/Results). 
This feasibility study demonstrated it is feasible to recruit patients to an SSI study involving collecting 
pre-operative rectal swabs. In addition, we have identified that pre-operatively a significant 
proportion of patients are colonised with antibiotic resistant Enterobacteriaceae. Resistance in this 
study is based on MICs relevant to the treatment of infection, as opposed to prophylaxis. It is not 
known whether MIC criteria for the treatment of infections are relevant to the efficacy of antibiotic 
prophylaxis. It is not our intention that these data should prompt changes to antibiotic prophylaxis 
regimens.  It is though intended that these data should stimulate debate on the contribution of 
microbiological testing to reducing SSI rates, and stimulate further research in this area.  
These are the first data we are aware of that associate rectal colonisation with antibiotic-resistant 
Enterobacteriaceae to SSI rates in colorectal surgery. We acknowledge that the data are limited by 
small numbers, as would be expected from a feasibility study; however, the study highlights 
important questions to be considered in the design of a full trial. In particular, the data raise the 
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possibility that there may be more of an SSI risk from E. coli, compared to Enterobacteriaceae other 
than E. coli which are resistant to antibiotic prophylaxis. 
Amoxicillin-clavulanic acid resistance in Enterobacteriaceae colonising the rectum are at rates that, if 
detected in infections, would lead to consideration of alternative antibiotic regimens. It is feasible, 
and important, to undertake further research into the impact and prophylaxis of antibiotic-resistant 
Enterobacteriaceae with regard to surgical site infections. 
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